Spots Global Cancer Trial Database for leukemia, lymphoblastic, acute
Every month we try and update this database with for leukemia, lymphoblastic, acute cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers | NCT00539656 | Acute Myeloid L... Leukemia, Lymph... Leukemia, Bilin... Leukemia, Myelo... | Ex vivo expansi... | 6 Months - 55 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT01186328 | Lymphoblastic L... Lymphoblastic L... Leukemia, Lymph... Leukemia, Lymph... | EZN-3042 Cytarabine Doxorubicin Prednisone Vincristine PEG-asparaginas... Methotrexate Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| "Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients | NCT00475280 | Leukemia, Lymph... | Geriatric asses... Stem cells auto... | 60 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia | NCT02888990 | Leukemia, Lymph... | Dasatinib | 55 Years - | Versailles Hospital | |
| MSC and HSC Coinfusion in Mismatched Minitransplants | NCT01045382 | Leukemia, Myelo... Leukemia, Lymph... Leukemia, Myelo... Myeloproliferat... Myelodysplastic... Multiple Myelom... Leukemia, Lymph... Hodgkin's Disea... Lymphoma, Non-H... | Mesenchymal ste... Isotonic soluti... | - 75 Years | University of Liege | |
| Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia | NCT03331211 | Leukemia, Lymph... | TKIs | 14 Years - | Nanfang Hospital, Southern Medical University | |
| Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) | NCT00179764 | Tumors Malignant Melan... Hematological M... Myelogenous Leu... Leukemia, Lymph... | Immunoablative ... Busulfan pharma... Central Nervous... | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes | NCT03235973 | Leukemia, Myelo... Leukemia, Lymph... | Fludarabine-Cla... | 18 Years - 70 Years | Institut Paoli-Calmettes | |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors | NCT01100658 | ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms... | Methylphenidate Placebo | 8 Years - 17 Years | University of Minnesota | |
| Unrelated Double Umbilical Cord Blood Units Transplantation | NCT01015742 | Leukemia, Myelo... Leukemia, Lymph... Leukemia, Myelo... | Stem cell Trans... | 1 Year - 50 Years | Tehran University of Medical Sciences | |
| Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia | NCT01158885 | Minimal Residua... Leukemia, Lymph... Leukemia, Myelo... | Clofarabine Cytarabine intr... Methotrexate Intrathecal (IT... | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia | NCT02888990 | Leukemia, Lymph... | Dasatinib | 55 Years - | Versailles Hospital | |
| Phase I, Dose Escalation Study of Decitabine | NCT02264873 | Leukemia, Lymph... Leukemia, Myelo... Hematopoetic My... | Decitabine | 1 Year - 30 Years | University of Florida | |
| Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes | NCT03235973 | Leukemia, Myelo... Leukemia, Lymph... | Fludarabine-Cla... | 18 Years - 70 Years | Institut Paoli-Calmettes | |
| A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors | NCT00186901 | Leukemia, Lymph... Osteoporosis | Calcium carbona... Placebo | - | St. Jude Children's Research Hospital | |
| A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors | NCT00186901 | Leukemia, Lymph... Osteoporosis | Calcium carbona... Placebo | - | St. Jude Children's Research Hospital | |
| Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies | NCT00619879 | Leukemia, Myelo... Leukemia, Lymph... Leukemia, Myelo... Myeloproliferat... Lymphoma, Malig... | Myeloablative C... Myeloablative C... Hematopoietic P... CNS radiation t... | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| "Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients | NCT00475280 | Leukemia, Lymph... | Geriatric asses... Stem cells auto... | 60 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Pilot Study of Unrelated Cord Blood Transplantation | NCT00916045 | Leukemia, Myelo... Myelodysplastic... Leukemia, Lymph... Lymphoma, Non-H... Hodgkin Disease Chronic Lymphoc... | Thiotepa Fludarabine Intravenous bus... Thymoglobulin Ciclosporin Mycophenolate m... Fludarabine Cyclophosphamid... Radiotherapy Thymoglobulin Ciclosporin Mycophenolate m... Fludarabine Melphalan Thymoglobulin Ciclosporin Mycophenolate m... | 18 Years - 70 Years | King's College Hospital NHS Trust | |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors | NCT01100658 | ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms... | Methylphenidate Placebo | 8 Years - 17 Years | University of Minnesota | |
| Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia | NCT01976442 | Leukemia, Myelo... Leukemia, Lymph... | - 50 Years | University of Rochester | ||
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT01186328 | Lymphoblastic L... Lymphoblastic L... Leukemia, Lymph... Leukemia, Lymph... | EZN-3042 Cytarabine Doxorubicin Prednisone Vincristine PEG-asparaginas... Methotrexate Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors | NCT00186901 | Leukemia, Lymph... Osteoporosis | Calcium carbona... Placebo | - | St. Jude Children's Research Hospital | |
| Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch | NCT03627208 | Leukemia, Lymph... ALL, Childhood | 2 Years - 40 Years | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
